Momelotinib Impurity 12 | CAS 1341552-19-9 - Request Quote
Momelotinib Impurity 12
| SZ CAT No: | SZ-M168023 |
| CAS No | 1341552-19-9 |
| Mol.F. | C11H15N3O2 |
| Mol.Wt. | 221.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Momelotinib Impurity 12 is chemically 1-(4-Morpholinophenyl)urea. Momelotinib Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Momelotinib Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Momelotinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1341552-19-9
Purchase 1341552-19-9
Order 1341552-19-9
Enquire 1341552-19-9
price of 1341552-19-9
1341552-19-9 Supplier
1341552-19-9 Manufacturer
1341552-19-9 Exporter
buy high quality Momelotinib Impurity 12
Purchase Momelotinib Impurity 12
Momelotinib Impurity 12 suppliers
Momelotinib Impurity 12 manufacturers
Momelotinib Impurity 12 price
Order Momelotinib Impurity 12
Enquire Momelotinib Impurity 12
Momelotinib Impurity 12 cost
Momelotinib Impurity 12 Supplier
Momelotinib Impurity 12 Distributor
Momelotinib Impurity 12 for Method Validation
Momelotinib Reference Standard
Momelotinib Impurity 12 for ANDA Filing
Momelotinib Impurity 12 for Forced Degradation Studies
Momelotinib Impurity 12 Identification Standards
Momelotinib Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


